Advanced search
Publication Cover
Acta Oncologica Volume 57, 2018 - Issue 3
Journal homepage
2,184
Views
48
CrossRef citations to date
0
Altmetric
LETTERS TO THE EDITOR

Have we reached proton beam therapy dosimetric limitations? – A novel robust, delivery-efficient and continuous spot-scanning proton arc (SPArc) therapy is to improve the dosimetric outcome in treating prostate cancer

Xuanfeng DingDepartment of Radiation Oncology, Beaumont Health, Royal Oak, MI, USACorrespondence[email protected]
,
Xiaoqiang LiDepartment of Radiation Oncology, Beaumont Health, Royal Oak, MI, USA
,
An QinDepartment of Radiation Oncology, Beaumont Health, Royal Oak, MI, USA
,
Jun ZhouDepartment of Radiation Oncology, Beaumont Health, Royal Oak, MI, USA
,
Di YanDepartment of Radiation Oncology, Beaumont Health, Royal Oak, MI, USA
,
Craig StevensDepartment of Radiation Oncology, Beaumont Health, Royal Oak, MI, USA
,
Daniel KraussDepartment of Radiation Oncology, Beaumont Health, Royal Oak, MI, USA
&
Peyman KabolizadehDepartment of Radiation Oncology, Beaumont Health, Royal Oak, MI, USA
 show all
Pages 435-437 | Published online: 03 Aug 2017
 
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days
Click to increase image sizeClick to decrease image sizeFree first page

Disclosure statement

No potential conflict of interest was reported by the authors. A patent based on the Spot-Scanning Arc Proton therapy is pending.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related Research Data

Have we reached proton beam therapy dosimetric limitations? – A novel robust, delivery-efficient and continuous spot-scanning proton arc (SPArc) therapy is to improve the dosimetric outcome in treating prostate cancer
Source: Taylor & Francis
Have we reached proton beam therapy dosimetric limitations? – A novel robust, delivery-efficient and continuous spot-scanning proton arc (SPArc) therapy is to improve the dosimetric outcome in treating prostate cancer
Source: Figshare
Have we reached proton beam therapy dosimetric limitations? – A novel robust, delivery-efficient and continuous spot-scanning proton arc (SPArc) therapy is to improve the dosimetric outcome in treating prostate cancer
Source: Figshare

Linking provided by 
Download PDF

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.